Delivery Order 36C25223D0046-36C25224N0279

Award Date 3/1/24
Potential Completion Date 2/28/26
Potential Value $216K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>RLS USA Inc. was awarded a $176,049.49 firm fixed price delivery order against an unspecified multiple award contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17. The contract is for the delivery of radiopharmaceutical products to support the agency's healthcare programs with no set-aside designation applied. Performance will occur in Lake Zurich, Illinois through July 27, 2022. No subcontractors were identified.</p>
This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $607,676.91 firm fixed price delivery order contract to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, and technetium-99m, to support nuclear medicine services at the Milwaukee VA Medical Center. This delivery order contract is likely part of a...
This federal contract award is to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate. The contract, valued at $216,261.99, is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). RLS (USA) Inc. operates 31 radiopharmacy facilities across 18...
This is a $1,415,722.03 firm fixed price contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine operations at VA medical facilities. RLS USA Inc. has received numerous federal contracts from VA and the Defense Health Agency to supply medical isotopes such...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed price delivery order contract to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of non-pet radiopharmaceuticals. The contract, valued at $232,388.97, has an ultimate completion date of March 31, 2025. RLS (USA) Inc. is a small business that specializes in providing a range of medical isotopes and radiopharmaceutical products to support nuclear medicine diagnostic services at VA medical centers...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to RLS USA Inc., a foreign-owned, for-profit radiopharmacy, to provide various radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and other medical isotopes. The contract has a total potential value of $2,930,951.59 and includes a base year plus four one-year option periods, with deliveries to the VA Long Beach Healthcare System. The...
This is a federal contract award to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of radiopharmaceuticals and related supplies, with a ceiling value of $179,605.38 and a performance period through March 31, 2026. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 21 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $378,281.55, is for the delivery of radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and the Defense Health Agency...
This firm-fixed price federal contract award, valued at $425,794.77, was issued by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine diagnostic procedures at VA medical centers and military treatment facilities over a 6-month period ending in July 2024. RLS (USA) Inc. operates a nationwide network of 31 radiopharmacy facilities,...
  • 36C25223D0046
    Indefinite Delivery Contract
  • 36C25223D0046-36C25224N0279
    Delivery Order

RLS USA Inc. has been awarded a firm fixed-price delivery order valued at $216,261.99 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The order was issued under an existing contract vehicle to provide radiopharmaceutical products in support of nuclear medicine services. Specifically, RLS will supply gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and other medical isotopes. Performance will take place in Lake Zurich, Illinois through February 2026. As a foreign-owned, for-profit organization, RLS owns and operates 31 radiopharmacies across the United States to offer molecular imaging products to federal agencies like the VA and Defense Health Agency. This delivery order was issued without a set-aside designation from existing blanket purchase agreements and indefinite delivery contracts held by RLS that facilitate as-needed ordering of specified diagnostic imaging agents for VA and DHA medical facilities.

Generated 3/2/24, 9:50 AM